Distinct mutational pattern of myelodysplastic syndromes with and without 5q– treated with lenalidomide

Saved in:
Bibliographic Details
Published inBritish journal of haematology Vol. 189; no. 4; pp. e133 - e137
Main Authors Adema, Vera, Palomo, Laura, Toma, Andrea, Kosmider, Olivier, Fuster‐Tormo, Francisco, Benito, Rocío, Salgado, Rocío, Such, Esperanza, Larrayoz, María José, Xicoy, Blanca, Hernandez‐Sanchez, Jesus Maria, Maietta, Paolo, Neef, Alexander, Fontenay, Michaela, Ibañez, Mariam, Diez-Campelo, Maria, Alvarez, Sara, Maciejewski, Jaroslaw P., Fenaux, Pierre, Sole, Francesc
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.05.2020
Subjects
del(5q)
Hematology
Humans
Immunotherapy
lenalidomide
Lenalidomide - pharmacology
Lenalidomide - therapeutic use
Mutation
mutations
Myelodysplastic syndrome
Myelodysplastic syndromes
Myelodysplastic Syndromes - drug therapy
non‐del(5q)
Targeted cancer therapy
mutations
lenalidomide
del(5q)
non-del(5q)
Myelodysplastic syndromes
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
The project was conceptualised by Vera Adema and Francesc Sole. Vera Adema analysed sequencing data, collected clinical information, designed the study, and wrote the paper. Laura Palomo helped with sequencing analysis, clinical data collection and helped in manuscript preparation. Data performing, analysis, clinical information collection was done by Andrea Toma, Olivier Kosmider, Francisco Fuster-Tormo, Rocío Benito, Rocío Salgado, Esperanza Such, María José Larrayoz, Jesus Maria Hernandez-Sanchez, Paolo Maietta, Alexander Neef, Michaela Fontenay, Mariam Ibañez, Maria Diez Campelo, Sara Alvarez. Jaroslaw P. Maciejewski and Pierre Fenaux, provided patients and important help on the manuscript. All co-authors revised the paper.
Author contributions
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.16558